Cohort study: Among women with congenital Long QT, progestin oral contraceptives were linked to a 2.8-fold increased risk of cardiovascular events in those not receiving B-blocker therapy.
15 Oct, 2021 | 02:17h | UTCUse of oral contraceptives in women with congenital long QT syndrome – Heart Rhythm (link to abstract – $ for full-text)
Commentary: Progestin OCs Triple CV Events in Women With Congenital Long QT – TCTMD